tofacitinib 10 MG Oral Tablet

RxCUI
2048566
RxNorm name
tofacitinib 10 MG Oral Tablet
Display name
Tofacitinib (Oral Pill)
Full name
tofacitinib 10 MG Oral Tablet
Term type
SCD
Status
Active
Strength
10 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-08 10:04:59

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082018
Active start
082018
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
tofacitinib citrate10 MG / 1 EACHtofacitinibtofacitinib

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
tofacitinib1357536

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
33342-542-0933342-542Tofacitinib TofacitinibMacleods Pharmaceuticals LimitedANDA219530
33342-542-4333342-542Tofacitinib TofacitinibMacleods Pharmaceuticals LimitedANDA219530
33342-542-5433342-542Tofacitinib TofacitinibMacleods Pharmaceuticals LimitedANDA219530
42571-377-0542571-377TOFACITINIB tofacitinibMicro Labs LimitedANDA209738
42571-377-3042571-377TOFACITINIB tofacitinibMicro Labs LimitedANDA209738
42571-377-6042571-377TOFACITINIB tofacitinibMicro Labs LimitedANDA209738
42571-377-7642571-377TOFACITINIB tofacitinibMicro Labs LimitedANDA209738
51991-963-0651991-963Tofacitinib Tofacitinib CitrateBreckenridge Pharmaceutical, Inc.ANDA209633
59651-460-6059651-460TOFACITINIB TOFACITINIBAurobindo Pharma LimitedANDA215356
60505-6264-560505-6264Tofacitinib tofacitinibApotex Corp.ANDA218096
60505-6264-660505-6264Tofacitinib tofacitinibApotex Corp.ANDA218096
68254-5012-168254-5012TOFACITINIB CITRATE TOFACITINIB CITRATECONCORD BIOTECH LIMITEDANDA218821
68254-5012-268254-5012TOFACITINIB CITRATE TOFACITINIB CITRATECONCORD BIOTECH LIMITEDANDA218821
68254-5012-368254-5012TOFACITINIB CITRATE TOFACITINIB CITRATECONCORD BIOTECH LIMITEDANDA218821
70069-842-0170069-842TOFACITINIB TOFACITINIBSomerset Therapeutics, LLCANDA220137
70710-1589-670710-1589tofacitinib tofacitinibZydus Pharmaceuticals USA Inc.ANDA209829
70710-1589-770710-1589tofacitinib tofacitinibZydus Pharmaceuticals USA Inc.ANDA209829
70710-1589-870710-1589tofacitinib tofacitinibZydus Pharmaceuticals USA Inc.ANDA209829
70771-1967-670771-1967tofacitinib tofacitinibZydus Lifesciences LimitedANDA209829
70771-1967-770771-1967tofacitinib tofacitinibZydus Lifesciences LimitedANDA209829
70771-1967-870771-1967tofacitinib tofacitinibZydus Lifesciences LimitedANDA209829
72205-140-1872205-140Tofacitinib TofacitinibNovadoz Pharmaceuticals LLCANDA217299
72205-140-2872205-140Tofacitinib TofacitinibNovadoz Pharmaceuticals LLCANDA217299
72205-140-6072205-140Tofacitinib TofacitinibNovadoz Pharmaceuticals LLCANDA217299
72865-367-1272865-367Tofacitinib TofacitinibXLCare Pharmaceuticals IncANDA219530
72865-367-6072865-367Tofacitinib TofacitinibXLCare Pharmaceuticals IncANDA219530
73190-101-6073190-101Tofacitinib TofacitinibAvKAREANDA217299
84677-055-6084677-055Tofacitinib tofacitinibGolden State Medical Supply, Inc.ANDA218096
85972-122-6085972-122TOFACITINIB CITRATE TOFACITINIB CITRATEStellon Biotech Inc.ANDA218821

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA21953033342-542Tofacitinib TofacitinibANDAMacleods Pharmaceuticals Limited
ANDA20973842571-377TOFACITINIB tofacitinibANDAMicro Labs Limited
ANDA20963351991-963Tofacitinib Tofacitinib CitrateANDABreckenridge Pharmaceutical, Inc.
ANDA21535659651-460TOFACITINIB TOFACITINIBANDAAurobindo Pharma Limited
ANDA21809660505-6264Tofacitinib tofacitinibANDAApotex Corp.
ANDA21882168254-5012TOFACITINIB CITRATE TOFACITINIB CITRATEANDACONCORD BIOTECH LIMITED
ANDA22013770069-842TOFACITINIB TOFACITINIBANDASomerset Therapeutics, LLC
ANDA20982970710-1589tofacitinib tofacitinibANDAZydus Pharmaceuticals USA Inc.
ANDA21729972205-140Tofacitinib TofacitinibANDANovadoz Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 32 matching rows.

NDC11, Source, Active table
NDC11SourceActive
33342054209rxnav_ndcsyes
33342054243rxnav_ndcsyes
33342054254rxnav_ndcsyes
33342054266rxnav_ndcsyes
42571037705rxnav_ndcsyes
42571037713rxnav_ndcsyes
42571037730rxnav_ndcsyes
42571037760rxnav_ndcsyes
42571037776rxnav_ndcsyes
51991096306rxnav_ndcsyes
51991096377rxnav_ndcsyes
59651046060rxnav_ndcsyes
60505626405rxnav_ndcsyes
60505626406rxnav_ndcsyes
68254501201rxnav_ndcsyes
68254501202rxnav_ndcsyes
68254501203rxnav_ndcsyes
70069084201rxnav_ndcsyes
70710158906rxnav_ndcsyes
70710158907rxnav_ndcsyes
70710158908rxnav_ndcsyes
70771196706rxnav_ndcsyes
70771196707rxnav_ndcsyes
70771196708rxnav_ndcsyes
72205014018rxnav_ndcsyes
72205014028rxnav_ndcsyes
72205014060rxnav_ndcsyes
72865036712rxnav_ndcsyes
72865036760rxnav_ndcsyes
73190010160rxnav_ndcsyes
84677005560rxnav_ndcsyes
85972012260rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 15 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TofacitinibTOFACITINIBXLCare Pharmaceuticals Inc10403307-e2f9-44d1-bc72-552fdba299d12026-11-02Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 72865-367-60
ndc (package): 72865-367-12
ndc (product): 72865-367
ndc11 (package): 72865036712
ndc11 (package): 72865036760
rxcui: 2048566
TofacitinibTOFACITINIBMacleods Pharmaceuticals Limited9b654f0d-7705-4880-9e9d-ad3a51e56b562026-10-22Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 33342-542-09
ndc (package): 33342-542-43
ndc (package): 33342-542-54
ndc (product): 33342-542
ndc11 (package): 33342054254
ndc11 (package): 33342054266
ndc11 (package): 33342054209
ndc11 (package): 33342054243
rxcui: 2048566
TofacitinibTOFACITINIBApotex Corp.7d4f5cfa-35a8-1458-a609-f6b417946abb2026-10-21Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 60505-6264-5
ndc (package): 60505-6264-6
ndc (product): 60505-6264
ndc11 (package): 60505626406
ndc11 (package): 60505626405
rxcui: 2048566
TOFACITINIB CITRATETOFACITINIB CITRATEStellon Biotech Inc.89eb2ffc-02d9-4b46-b480-e9b10af330272026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 85972-122-60
ndc (product): 85972-122
ndc11 (package): 85972012260
rxcui: 2048566
TOFACITINIB CITRATETOFACITINIB CITRATECONCORD BIOTECH LIMITED6c33e5b4-4843-4a80-a4f8-435bfceddc2a2026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 68254-5012-3
ndc (package): 68254-5012-1
ndc (package): 68254-5012-2
ndc (product): 68254-5012
ndc11 (package): 68254501202
ndc11 (package): 68254501201
ndc11 (package): 68254501203
rxcui: 2048566
XELJANZTOFACITINIBU.S. Pharmaceuticals68e3d6b2-7838-4d2d-a417-09d919b43e132026-10-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2048566
tofacitinibTOFACITINIBZydus Pharmaceuticals USA Inc.21a89264-8047-40ac-8b10-fa64610725092026-10-05Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 70710-1589-6
ndc (package): 70710-1589-8
ndc (package): 70710-1589-7
ndc (product): 70710-1589
ndc11 (package): 70710158906
ndc11 (package): 70710158907
ndc11 (package): 70710158908
rxcui: 2048566
TOFACITINIBTOFACITINIBMicro Labs Limitedffa6819b-23a4-478b-8fb7-cc90e8142fc52026-09-25Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 42571-377-76
ndc (package): 42571-377-60
ndc (package): 42571-377-30
ndc (package): 42571-377-05
ndc (product): 42571-377
ndc11 (package): 42571037713
ndc11 (package): 42571037730
ndc11 (package): 42571037776
ndc11 (package): 42571037705
ndc11 (package): 42571037760
rxcui: 2048566
TofacitinibTOFACITINIBNovadoz Pharmaceuticals LLC253635c8-1ea7-41ba-b216-dea5e3305c472026-09-01Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 72205-140-60
ndc (package): 72205-140-18
ndc (package): 72205-140-28
ndc (product): 72205-140
ndc11 (package): 72205014028
ndc11 (package): 72205014060
ndc11 (package): 72205014018
rxcui: 2048566
TofacitinibTOFACITINIBGolden State Medical Supply, Inc.58f22c41-87d2-e745-e063-6394a90a962e2026-08-13Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 84677-055-60
ndc (product): 84677-055
ndc11 (package): 84677005560
rxcui: 2048566
TofacitinibTOFACITINIBAvKARE5751321a-c904-44ae-e063-6394a90a26542026-07-23Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 73190-101-60
ndc (product): 73190-101
ndc11 (package): 73190010160
rxcui: 2048566
TOFACITINIBTOFACITINIBAurobindo Pharma Limited50962b08-99dd-ae73-e063-6394a90ad1eb2026-07-17Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 59651-460-60
ndc (product): 59651-460
ndc11 (package): 59651046060
rxcui: 2048566
TOFACITINIBTOFACITINIBSomerset Therapeutics, LLC2726c2b0-c763-4635-ac6b-4334c3a5a8bc2026-06-02Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 70069-842-01
ndc (product): 70069-842
ndc11 (package): 70069084201
rxcui: 2048566
tofacitinibTOFACITINIBZydus Lifesciences Limitedf4d0e580-74a8-496e-89a2-d74478c946bf2026-05-29Exact identifier
ndc (package): 70771-1967-7
ndc (package): 70771-1967-6
ndc (package): 70771-1967-8
ndc (product): 70771-1967
ndc11 (package): 70771196707
ndc11 (package): 70771196708
ndc11 (package): 70771196706
rxcui: 2048566
TofacitinibTOFACITINIB CITRATEBreckenridge Pharmaceutical, Inc.c963c610-52e5-43ab-aac6-3f7e5341b7642026-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 51991-963-06
ndc (product): 51991-963
ndc11 (package): 51991096377
ndc11 (package): 51991096306
rxcui: 2048566

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
cf74ba2f-afc5-4baa-8594-979c889a5831tofacitinib 10 MG Oral Tablet [PSN] · tofacitinib 10 MG Oral Tablet [SCD] · tofacitinib 10 MG (as tofacitinib citrate 16 MG) Oral Tablet [SY]353These highlights do not include all the information needed to use XELJANZ/XELJANZ XR safely and effectively. See full prescribing information for XELJANZ/XELJANZ XR. XELJANZ ® (tofacitinib) tablets, for oral use XELJANZ ® (tofacitinib) oral solution XELJANZ ® XR (tofacitinib) extended-release tablets, for oral use Initial U.S. Approval: 201220260312
68e3d6b2-7838-4d2d-a417-09d919b43e13tofacitinib 10 MG Oral Tablet [PSN] · tofacitinib 10 MG Oral Tablet [SCD] · tofacitinib 10 MG (as tofacitinib citrate 16 MG) Oral Tablet [SY]317These highlights do not include all the information needed to use XELJANZ/XELJANZ XR safely and effectively. See full prescribing information for XELJANZ/XELJANZ XR. XELJANZ ® (tofacitinib) tablets, for oral use XELJANZ ® (tofacitinib) oral solution XELJANZ ® XR (tofacitinib) extended-release tablets, for oral use Initial U.S. Approval: 201220260327

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
10403307-e2f9-44d1-bc72-552fdba299d1These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012XLCare Pharmaceuticals Inc | Evaric Pharmaceuticals Inc20261102
9b654f0d-7705-4880-9e9d-ad3a51e56b56These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Macleods Pharmaceuticals Limited20261022
7d4f5cfa-35a8-1458-a609-f6b417946abbThese highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Apotex Corp.20261021
89eb2ffc-02d9-4b46-b480-e9b10af33027These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Stellon Biotech Inc. | CONCORD BIOTECH LIMITED20261016
6c33e5b4-4843-4a80-a4f8-435bfceddc2aThese highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012CONCORD BIOTECH LIMITED20261016
10403307-e2f9-44d1-bc72-552fdba299d1These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012XLCare Pharmaceuticals Inc | Evaric Pharmaceuticals Inc20261009
21a89264-8047-40ac-8b10-fa6461072509These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited20261005
ffa6819b-23a4-478b-8fb7-cc90e8142fc5These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Micro Labs Limited20260925
ffa6819b-23a4-478b-8fb7-cc90e8142fc5These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Micro Labs Limited20260918
253635c8-1ea7-41ba-b216-dea5e3305c47These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED20260901
253635c8-1ea7-41ba-b216-dea5e3305c47These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED20260813
58f22c41-87d2-e745-e063-6394a90a962eTOFACITINIB TABLETS. These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Golden State Medical Supply, Inc.20260813
9b654f0d-7705-4880-9e9d-ad3a51e56b56These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Macleods Pharmaceuticals Limited20260806
7d4f5cfa-35a8-1458-a609-f6b417946abbThese highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Apotex Corp.20260804
ffa6819b-23a4-478b-8fb7-cc90e8142fc5These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Micro Labs Limited20260731
21a89264-8047-40ac-8b10-fa6461072509These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited20260730
5751321a-c904-44ae-e063-6394a90a2654TOFACITINIB tablets, for oral use These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. Initial U.S. Approval: 2012AvKARE20260723
50962b08-99dd-ae73-e063-6394a90ad1ebThese highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Aurobindo Pharma Limited | APL HEALTHCARE LIMITED20260717
50962b08-99dd-ae73-e063-6394a90ad1ebThese highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Aurobindo Pharma Limited | APL HEALTHCARE LIMITED20260706
253635c8-1ea7-41ba-b216-dea5e3305c47These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED20260606
21a89264-8047-40ac-8b10-fa6461072509These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited20260605
50962b08-99dd-ae73-e063-6394a90ad1ebThese highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Aurobindo Pharma Limited | APL HEALTHCARE LIMITED20260604
ffa6819b-23a4-478b-8fb7-cc90e8142fc5These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Micro Labs Limited20260604
9b654f0d-7705-4880-9e9d-ad3a51e56b56These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Macleods Pharmaceuticals Limited20260603
2726c2b0-c763-4635-ac6b-4334c3a5a8bcThese highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Somerset Therapeutics, LLC | Bluepharma - Industria Farmaceutica, S.a.20260602
89eb2ffc-02d9-4b46-b480-e9b10af33027These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Stellon Biotech Inc. | CONCORD BIOTECH LIMITED20260530
f4d0e580-74a8-496e-89a2-d74478c946bfTOFACITINIB tablets, for oral useZydus Lifesciences Limited20260529
7d4f5cfa-35a8-1458-a609-f6b417946abbThese highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Apotex Corp.20260520
c963c610-52e5-43ab-aac6-3f7e5341b764These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Breckenridge Pharmaceutical, Inc. | Towa Pharmaceutical Europe, S.L.20260514
c963c610-52e5-43ab-aac6-3f7e5341b764These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Breckenridge Pharmaceutical, Inc. | Towa Pharmaceutical Europe, S.L.20260507
21a89264-8047-40ac-8b10-fa6461072509These highlights do not include all the information needed to use TOFACITINIB TABLETS safely and effectively. See full prescribing information for TOFACITINIB TABLETS. TOFACITINIB tablets, for oral use Initial U.S. Approval: 2012Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited20260505
f4d0e580-74a8-496e-89a2-d74478c946bfTOFACITINIB tablets, for oral useZydus Lifesciences Limited20260505

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL04AFJanus-associated kinase (JAK) inhibitorsATC1-4tofacitinib
FDASPLN0000190858Janus Kinase InhibitorEPChas_epctofacitinib
FDASPLN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib
MEDRTD010880PiperidinesCHEMhas_ingredienttofacitinib
MEDRTD011743PyrimidinesCHEMhas_ingredienttofacitinib
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treattofacitinib
MEDRTN0000190857Janus Kinase InhibitorsMOAhas_moatofacitinib
MEDRTN0000008656Decreased HematopoiesisPEhas_petofacitinib
MEDRTN0000175550Decreased Immunologic ActivityPEhas_petofacitinib

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH10 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA209633
CODESANDAANDA209738
CODESANDAANDA209829
CODESANDAANDA215356
CODESANDAANDA217299
CODESANDAANDA218096
CODESANDAANDA218821
CODESANDAANDA219530
CODESANDAANDA220137
CODESSNOMEDCT1287191004
CODESVUID4037631
NAMESPrescribable Synonymtofacitinib 10 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File